This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings.
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1.
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.
For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1.
Some recent highlights and curiosities from the amazing world of cannabis science and therapeutics: CBD and autism. Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ).
CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also has anticonvulsant properties like CBD , as well as antibiotic properties.
Synthetic cannabis and cannabinoids have been connected to adverse effects time and time again. When it comes to synthetic or semi-synthetic cannabinoids, consumers are often unaware of the potential risks that come with consuming such forms of cannabis. Now, Project CBD is warning people about these potential risks. .
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. Consumers spent roughly $31.3
I counted over 175 talks and posters at the 33rd annual gathering of the International Cannabinoid Research Society (ICRS), which convened in Toronto at the end of June. In accordance with longstanding ICRS policy, all speakers presented new findings and data that had not yet been published in a peer-reviewed journal.
She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session.
Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.
The combination of minor cannabinoids THCV and CBG could help reduce bad eating habits like snacking and late-night binge eating, according to real-world data (RWD) collected from Cannigma readers last month. But the decrease in appetite is not just seen in the data – it’s also part of the lived experience.
Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. Treating Insomnia With Cannabinoids.
Close behind it — in both regards — is CBD, which despite having been studied for decades, has only become the center of a billion dollar industry in recent years. Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. CBD vs THC.
The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.
But newer research, including from this year, has indicated that cannabinoid suppositories do have clinical utility, and real-world data collected recently from Cannigma users shows that a CBD product based on a full extract cannabis oil (FECO) can significantly improve menstrual symptoms. And she got what she was looking for!
In the first part of this series, we reviewed recent research into the role of the CB2 cannabinoid receptor in cancer proliferation. After all, the CNS is the domain of its sibling, the CB1 cannabinoid receptor — the primary target of THC and the mediator of cannabis’ intoxicating effects.
BY NORML Analysis: Marijuana Use Data Fails to Support “Gateway Hypothesis” POSTED ON MAY 6, 2021 Boise, Idaho: Claims that the initiation of marijuana use is independently linked to the later use of other controlled substances are not supported by longitudinal data, according to a study published in the Journal of Experimental Criminology.
So it’s not surprising that products that combine cannabis and melatonin are making their way into legal marketing – and according to real world data gathered in a recent campaign on The Cannigma, it’s a winning combination. Is it the CBD, the CBN, or the melatonin? What’s in FOCL’s DEEP SLEEP, Full Spectrum+ Gummies?
Last week, the Food Standard Agency (“ FSA ”), the agency responsible for protecting public health in relation to food in England, Wales and Northern Ireland (collectively, the “UK”), cleared a path for the sale of CBD-infused food for the next 12 months. The EFSA guidance on cannabinoids strongly echoes the U.S.
When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. EG: Right, yeah.
Amid speculation on whether cannabidiol (CBD) can influence the intoxicating effects of d9-tetrahydrocannabinol (THC), a new study supports this idea, along with another unexpected and interesting finding related to a serious mental health disorder. Their aim was to explore whether CBD had anti-intoxicating effects.
and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. –(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS
It is possible to visually distinguish between high-CBD and high-THC cannabis strains just by looking at the physical properties of the plants as they grow, according to new research from scientists at the University of Alberta and two Canadian bioscience companies, PBG BioPharma and Egret Bioscience Ltd. It appears here with permission.
Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.
Imagine if scientific evidence emerged that cannabidiol (CBD), a fundamental medical cannabis extract, showed potential to prevent people from lapsing back into cocaine addiction after they had been rescued from their substance abuse disorder.
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news: CBD. Radicle Science study will evaluate effectiveness of various CBD products. Radicle Science, a healthtech B-corp that validates natural products, launched the Radicle ACES (Advancing CBD Education and Science) study. Nutritional Outlook.
We’ve been writing a lot on this blog about the regulation and sale of cannabidiol (“CBD”) products at the state and federal levels. The United States is not the only international actor, however, that is concerned with regulating the sale of CBD products, including CBD-infused foods. extracts of Cannabis sativa L.
The cannabinoid receptor CB1, primary target of THC in the brain, is known for mediating the cannabis high. Project CBD’s recent article on the passing of Raphael Mechoulam noted that the esteemed scientist believed CB2 should be a focus of future cannabinoid science. Copyright, Project CBD.
The research findings of the study, entitled “A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health,” was published this week in the journal Cannabis and Cannabinoid Research , Volume X, Number X, 2020. Fifty-eight percent of patients used CBD-dominant products.
Recent research on cattle fed with “hempseed cake” reports safe levels of THC and CBD in their beef. The research authors revealed that hemp seed cake, a by-product from hemp oil extraction, contained low cannabinoids, a healthy source of fiber, and crude protein for cattle and other animals. maximum THC concentration.
As with any pet well-being trend, once it involves CBD oil for dogs, there’s a great deal of knowledge floating around online. Of course, you wish to try and do what’s best for your pup, which ends up in the question: What do I would like to understand about CBD oil? What is CBD? How will CBD affect Dogs?
When you smoke cannabis, the cannabinoids enter the bloodstream through your lungs and throat, while edibles are metabolized inside the gut. Topical solutions can activate the cannabinoid receptors in the epidermis, but they do not penetrate deeply into the skin, so they’re most effective for localized treatment.
Recent scientific studies suggest that different cannabinoids and other cannabis-derived molecules (e.g Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Since then, numerous studies have explored cannabinoid activity in the different skin layers.
Statin medications deplete cannabinoid receptor function, according to a recent study by a team of distinguished Italian scientists. More troublesome, though, is that simvastatin alters genes involved in regulating cannabinoid receptors. Simvastatin also reduces cannabinoid receptor expression.
This shipment also marks the 11 th country to which SMGH has exported the Aureus™ branded products, which include a range of CBD, THC and CBG extracts and feminized seeds. NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. About Avicanna.
Every day more and more people are choosing CBD to address their pain symptoms. Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. Does CBD help with pain? In patients with fibromyalgia, a single inhalation of CBD 18.4
“A lot of patients ask for Rick Simpson Oil and high-CBD and high-THC hash oil and we cannot give them any credible information about how their cancer will respond to those substances,” Dr. Aguiar said. Aguiar said during an online panel discussion entitled “Cannabinoids and Cancer,” alongside Prof. seventyfour74/123rf). Shutterstock).
Note: You can make this DIY Cannabis Massage Oil in THC and/or CBD versions! THC and CBD, along with their un-decarboxylated counterparts THC-A and CBD-A (as well as cannabis’s lesser known cannabinoids) all have medical benefits when applied topically, so opt for full spectrum, whole plant when possible.
Chemotypes : Types of cannabis that are grouped by their most abundant cannabinoid. Chemovars: Types of cannabis which are loosely defined and grouped, based on at least one or two of the most abundant cannabinoids and two-to-four main terpenes. 10% THC and 30% THC plants could both be Type I, as long as THC is the major cannabinoid).
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content